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Abstract We developed a fluorescence in situ hybrid-
ization (FISH) method for the rapid detection of Proteus
spp. in urine, using a novel peptide nucleic acid (PNA)
probe. Testing on 137 urine samples from patients with
urinary tract infections has shown specificity and sensi-
tivity values of 98 % (95 % CI, 93.2–99.7) and 100 %
(95 % CI, 80,8–100), respectively, when compared with
CHROMagar Orientation medium. Results indicate that
PNA-FISH is a reliable alternative to traditional culture
methods and can reduce the diagnosis time to approxi-
mately 2 h.
Introduction
The genus Proteus is in the top five causes of urinary tract
infections (UTIs) [1, 2] and is related to the emergence of
complicated UTI (10–15 % of the cases), mainly for
immuno-compromised patients [3]. Proteus-associated UTIs
can be difficult to treat and are usually associated with
bladder and kidney stone formation, that can lead to the
obstruction of the urinary tract and catheters [3, 4]. The
three species of Proteus described as being associated with
UTIs are Proteus mirabilis, Proteus vulgaris and Proteus
penneri. P. mirabilis is considered to be the third most
common cause of complicated UTI (responsible for 12 %
of infections) and the second most common cause of
catheter-associated UTI’s (CAUTI’s) in long-term catheter-
ized patients (15 %) [4].
In terms of UTI diagnosis, current techniques require 24–
48 h to identify pathogenic species in urine [5, 6]. Chromo-
genic agars, such as CHROMagar Orientation and Candida
and MacConkey agar, have been developed to facilitate and
accelerate species recognition directly on primary media,
and have been widely adopted [7, 8]. However, studies
have shown that results obtained using the different
chromogenic media are not consistent, because micro-
organisms are not always detected on media, and the
colon counts and species recognized differed [6, 9]. In
the absence of expeditious microbiological diagnosis,
clinicians must initiate empirical antimicrobial treatment
without supportive laboratory data, which has led to the
emergence of resistant pathogens. Thus, a rapid molec-
ular approach would be beneficial.
Fluorescence in situ hybridization (FISH) is a molecular
method used to identify and quantify microbial populations
[10]. The combination of this method with peptide nucleic
acid (PNA) probes has shown to have many advantages
compared to conventional DNA-FISH [11]. PNA-FISH
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has been applied to the detection of several clinical relevant
microorganisms on a broad range of samples (for a review
see [12]). More recently, some studies have shown that its
implementation as a routine method in clinical laboratories
allows for a rational use of medicines, and reduces hospi-
talization times and mortality [13, 14].
In this work we developed and validated a new PNA-
FISH method for clinical detection of Proteus in urine
samples from patients with UTIs.
Material and methods
Culture maintenance
The bacterial strains used in this study are listed in Table 1.
Streptococcus and Campylobacter strains were maintained on
Columbia agar (Oxoid) supplemented with 5 % (vol/vol) defi-
brinated horse blood (Probiológica) and incubated at 37 °C,
10 % CO2 and 5 % O2 in a CO2 incubator (HERAcell
150, Waltham). Single colonies were streaked onto fresh
plates every 2–3 days. All remaining bacterial species were
maintained on Tryptic Soy Agar (Sigma) at 37 °C and
restreaked every 24 h.
PNA probe design and theoretical evaluation
To identify potentially useful oligonucleotides for use as
probe, the Primrose program was used coupled with the
16S rRNA databases of the Ribosomal Database Project II
(RDPII) (http://rdp.cme.msu.edu/html) [15, 16]. Criteria for
the selection of the PNA probe included: high number of
Proteus detected, low number of non-targets detected, no
self-complementary structures, and lower number of non-
target sequences with one mismatch. The selected se-
quence was synthesized (Panagene, South Korea) and
the N-terminus attached to Alexa fluor 488 via a double
AEEA linker. The theoretical specificity and sensitivity
of the probe was evaluated with the updated databases
available at RDPII (RDP Release 10, Update 28, January
2012) and NCBI.
Specificity was calculated as nPs/(TnP)x100, where nPs
stands for the number of non-Proteus strains that did not
react with the probe and TnP for total of non-Proteus strains
examined. Sensitivity was calculated as Ps/(TPs)x100,
where Ps stands for the number of Proteus strains detected
by the probe and TPs for the total number of Proteus strains
in the databases.
Hybridization procedure
The hybridization procedures were performed as previously
reported [17]. For the protocol optimization the hybridization
was repeated but hybridization and washing temperatures (57
to 65 °C) as well as the hybridization time (45 and 90 min)
were changed.
After the hybridization, samples were allowed to air-
dry, mounted with one drop of non-fluorescent immer-
sion oil (Merck) and covered with coverslips. Samples
were visualized in an epifluorescence microscope (Olym-
pus BX51) with an FITC filter. A negative control was
performed simultaneously, with hybridization solution
without probe.
Proteus probe specificity test
The specificity of the probe was tested using 22 Proteus
strains of different species and 52 other strains. These
latter strains included 32 taxonomically related strains of
the same family, and 20 strains of different orders, classes or
phyla.
Detection limit in artificial urine
To evaluate the detection limit, artificial urine samples,
prepared as reported before [18], were inoculated with
P. vulgaris ATCC29905 and P. mirabilis ATCC21100
(grown overnight in artificial urine at 37 °C, 120 rpm)
with concentrations ranging from 1×102 to 1×107 CFU/
mL. As the detection limit reported for PNA-FISH is
2×105 cells/mL [17], 20 mL samples (which were 20-
fold concentrated by centrifugation at 10,000 g for
5 min) were used before starting the hybridization pro-
cedure. This was performed in suspension or on glass slides as
described above.
To quantify the number of cells lost during the PNA-
FISH method, samples were taken during the different pro-
cedure steps (inoculum in water, paraformaldehyde, ethanol,
washing solution 1 and washing solution 2), stained with
DAPI and counted under the microscope.
Quantification of cells by DAPI or PNA-FISH was
obtained by counting a total of 15 fields with an area of
0.0158 mm2. The average was used to calculate total
cells per mL of sample. These experiments were performed
three times.
Detection in urine samples
To evaluate method performance on real samples, 78 urine
samples from outpatients with symptoms of UTI, were col-
lected in sterile flasks at Hospital de S. João (Porto, Portugal)
and Laboratório de Análises Clínicas S. Lázaro (Braga, Por-
tugal) and simultaneously analyzed by PNA-FISH and
CHROMagar Orientation medium. For PNA-FISH analyses,
hybridization was performed as described above, but for tur-
bid urine samples only 1 ml was pelleted by centrifugation.
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For culture analyses, a 10-μL volume of each sample was
spread on CHROMagar Orientation and incubated for 24 or
48 h at 37 °C. Only samples with Proteus concentrations
higher than 1×104 CFU/ml were considered positive for UTI.








Proteus mirabilis ATCC 29906a, ATCC 14153a, ATCC 21100a, 414b, 417b, 933b, M13b,
PL050596b, PL050835b, PL49417b, PL49905b and PL50359b
+
Proteus vulgaris ATCC 6380a, ATCC 6896a, ATCC 9484a, ATCC 29905a, M12b, 404b and 43b +
Proteus penneri ATCC 33519a, CDC2518-74a +
Proteus hauseri ATCC 13315a +
Cronobacter sakazakii ATCC 29544a −
Cronobacer malonaticusb −
Enterobacter aerogenes CECT 684a −





Escherichia coli K12a, ATCC 25922a, N5b and N9b −
Escherichia hermannii ATCC 33650a −
Escherichia vulneris ATCC 29943a −
Klebsiella oxytoca ATCC 13182a −
Klebsiella pneumoniae ATCC 11296a −
Citrobacter freundiib −
Serratia plymuthica F4b −
Morganella morganii CDC4195-69a −
Salmonella bongori SGSC 3100a, SGSC 3103a −
Salmonella enterica subp. enterica serovar Enteritidis SGSC 2474a −
Salmonella enterica subp. enterica serovar Newport SGSC 2493a −
Salmonella enterica subp. enterica serovar Panama SGSC 2497a −
Salmonella enterica subp. enterica serovar Paratyphi C SGSC 2506a −
Salmonella enterica subsp. enterica serovar Indiana SGSC 2482a −
Salmonella enterica subp. enterica serovar Dublin SGSC 2470a −
Shigella boydii ATCC 9207a −
Shigella dysenteriae ATCC 11835a −
Shigella sonnei ATCC 25931a −
Yersinia kritensenii PL115185b −
Yersinia enterocolitica subsp. enterocolitica PL129178b −
Pseudomonas aeuroginosa ATCC 10145a −
Pseudomonas fluorescens ATCC 13525a −
Campylobacter colib
Campylobacter jejunib
Staphylococcus aureus subsp. aureus ATCC 13565a, ATCC 12600a, ATCC 6538a and 239b −
Staphylococcus sciurib −
Staphylococcus epidermidis ATCC 35983a; ATCC 35984a; ATCC 1798a; ATCC 14990a −
Streptococcus mutans UCb, UPb
Enterococcus faecalis ATCC 27285a
Enterococcus faecium ATCC 19434a
Listeria monocytogenes CECT 4031Ta, 747b, 924b −
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Results
Probe design
The selection of oligonucleotides was based on the 16S
rRNA comparison of all Proteus spp. strains in the RDP II
database. Several potentially useful oligonucleotides were
identified using the PRIMROSE software. From the possi-
ble probes identified, and based on criteria described in
“Material and Methods”, we selected the following PNA
oligomer sequence: 5′-GCCCCTGCTTTGGTC- 3′. This
probe hybridizes between positions 190 and 204 of the P.
mirabilis strain HI4320 16S rRNA (accession number:
NC_010554.1) and was thus designated ProPNA190.
The search showed that the ProPNA190 detected 135 of
140 Proteus sequences present in the database (last accession,
March 2012), and thus a sensitivity of 96.4 % was obtained.
The five non-detected Proteus sequences were three P. mir-
abilis (accession number: S000806301, S002305608 and
S002409155), one P. vulgaris (S000414235) and one Proteus
spp. (S002950968). To confirm this result the five sequences
of rDNA were aligned with the probe reverse-complement.
We observed that sequence S002950968 was incomplete and
did not include the region where the probe hybridizes.
Sequences S000414235, S000806302, S002305608, and
S002409155 present one mismatch of base pairs compared
to ProPNA190 (Supplemental material, Fig. S1). For the P.
mirabilis S000806301 strain the mismatch corresponds to an
R (A/G) in the rRNA sequence, meaning that this strain might
also be detectable with the probe. From the 495940 16S rRNA
sequences analyzed, ProPNA190 also detected four non-Pro-
teus sequences: one Orientia tsutsugamushi (S000266975),
two Idiomarina sediminum (S000842774 and S002446946)
and one Pseudidiomarina sp. S001098108 (Pseudidiomarina
spp. inclusion in Idiomarina genus have been recently pro-
posed [19]). However, none of these non-targets is relevant to
the diagnosis of urinary infection [20, 21]. As we analyzed
495,851 non-Proteus strains and only two were detected by
the probe, a theoretical specificity of 99.99 % was obtained.
Probe specificity and sensitivity testing
The hybridization conditions for ProPNA190 were optimized
and a strong signal-to-noise ratio was obtained from 55 °C to
65 °C for 45 min of hybridization. However, to achieve an
appropriate specificity, 65 °C was used for all subsequent tests.
After optimization, the specificity and sensitivity of the PNA
probe were tested on 22 representative Proteus strains and
another 52 strains, including common urinary pathogens, such
as E. coli, E. faecalis, K. pneumonia and Staphylococcus [22].
As shown in Table 1, all Proteus strains were detected,
whereas no hybridization was observed for the other species
used. Therefore, experimental specificity and sensitivity were
both 100 % (sensitivity, 95 % CI, 81.5–100, and specificity,
95 % CI, 91.4–100).
Detection limit in artificial urine
To achieve the desired sensitivity, and considering the
reported detection limit for PNA-FISH of 2×105 cells/mL
[17], samples were 20-fold concentrated by centrifugation
before the hybridization procedure.
As the PNA-FISHmethod also involves centrifugation steps,
the number of cells lost during the procedure was determined to
assure that it did not interfere with the PNA-FISH result. We
observed that the percentage of cells lost during the procedure
was 7–8% (Table S1), and the total cells lost from the initial step
till the end of the PNA-FISH method was 26.39 % (±7.46).
Therefore, and considering that we are measuring total cells that
are even higher than CFU counts (for Proteus in artificial urine,
the number of cells detected by cultivability was 85.75±
3.65 %), we were assured that this loss does not interfere with
the outcome. In Fig. 1 we can observe the results obtained for
each bacterial concentration. This procedure was able to detect
1×104 CFU/mL (corresponding to ∼10 cells/microcopy field;
Supplemental material Table S2), while concentrations lower
than this were not detected. However, if a concentration of 1×
105 CFU/mL is desired as indicative of infection, a maximum
initial urine volume of 2 mL should be used.
Detection of Proteus in clinical urine specimens
To evaluate method performance on real samples, urine from
outpatients with symptoms of UTI were collected and simul-
taneously analyzed by PNA-FISH and CHROMagar Orienta-
tion medium. For CHROMagar Orientation, only samples
with Proteus concentrations higher than 1×104 CFU/ml were
considered positive for UTI. For PNA-FISH a positive out-
comewas always considered indicative of UTI (Fig. 2 shows a
positive result for Proteus presence in a real urine sample). As
shown in Table 2, from the 137 samples analyzed, only 23
were positive for Proteus presence using the CHROMagar
Orientation medium. Using this PNA-FISH method, no false
negative results were observed, but two false positive results
were obtained. As such, the observed value of sensitivity was
100 %, with a confidence interval (CI) of 95 %, from 80.8 to
100 %, and for specificity a value of 98 % was determined,
with a CI from 93.2 to 99.7 %. Results were quite consistent
between the two techniques, with the main difference being
the time required to achieve the final result.
Discussion
The Proteus genus includes five species, P. vulgaris, P.
mirabilis, P. penneri, P. hauseri and P. myxofaciens, which
784 Eur J Clin Microbiol Infect Dis (2013) 32:781–786
exist in soil, polluted water, and intestines of humans and a
wide variety of animals [23, 24]. For the probe specificity
test, we included four Proteus species: P. vulgaris, P. mirabilis,
P. penneri and P. hauseri, though only P. vulgaris, P. mirabilis
and P. penneri species are reported as causing UTIs [22, 23]. P.
hauseri is not usually reported as a cause of UTI’s, because it is
considered the genomospecies 3 of P. vulgaris species [25].
Additionally, 32 taxonomically related strains of the same fam-
ily (Shigella, Klebsiella, Citrobacter, Pantoea, Yersinia, Enter-
obacter, Escherichia and Serratia, Morganella) and 20 strains
of different orders (Pseudomonas), classes (Campylobacter) or
phyla (Listeria, Streptococcus, Enterococcus and Staphylococ-
cus) were also tested, and no cross-hybridization was observed
for the non-Proteus strains tested.
After the probe testing the PNA FISH was adapted for the
detection of UTIs caused by Proteus spp. in urine samples.
Currently, urinalysis and the detection of nitrites in urine are
the most used UTI diagnosis assays [26]. However, they are
not able to identify the pathogen. The only assay capable of
this and of establishing a definitive diagnosis of UTI is urine
culture, a method pioneered by Koch and Petri in the 1880s,
and refined during the last several decades. The latest urine
culture technology allows the identification of various organ-
isms in a single test since various pathogens grown on a
chromogenic medium produce a color change that is species
specific. However these tests usually require 24–48 h, mean-
ing that clinicians need to start the empirical treatment before
having urine culture result [5, 6]. An urine culture of at least
105 CFU/mL of any single type of bacterium has traditionally
been believed to provide conclusive evidence of UTI [26, 27];
although, for catheterized individuals this value can be lower
(∼104 CFU/ml) [28]. Therefore, as Proteus is associated with
the infection of catheterized patients [3, 4], a threshold of 1×
104 CFU/mL was defined. Using the PNA-FISH method
described here, we were able to detect as low as 1×104
CFU/mL in approximately 2 h, with similar accuracy (sensi-
tivity of 100 % and specificity of 98 %) to the standard culture
method (Chromagar Orientation).
Several researchers have been working on the development
of new techniques to reduce the time and cost of urine culture
processing. However, while some methods, such as PCR, are
unable to distinguish between clinically significant or non-
significant bacteriuria, others like the use of chromogenic
Fig. 1 Epifluorescence
detection of P. vulgaris ATCC
29905 using the ProPNA190
probe in artificial urine with 1×
107 (a), 1×106 (b), 1×105 (c)
and 1×104 (d) CFU per mL of
urine
Fig. 2 Detection of Proteus in a real urine sample using the
ProPNA190 probe. a Image at the green filter capable of detecting
the Alexa 488 (BP 470–490, FT 500, LP 516 for LmPNA1253). b
Image at the red filter (BP 530–550, FT 570, LP 591)
Table 2 PNA-FISH and CHROMagar results for Proteus presence in
real urine samples. The presence of Proteus in CHROMagar was
considered only for concentrations higher than 1×104 CFU/ml of urine
Measurement CHROMagar
Absence Presence Total
PNA-FISH Positive 2 21 23
Negative 114 0 114
Total 116 21 137
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media are limited by the slow growth, or inability to grow, of
some microorganisms [6, 9, 29].
The protocol presented in this work has been demonstrated
to be a reliable alternative to the currently used culture-based
techniques. It also presented an appropriate level of sensitivity
for detection of clinically relevant concentrations of bacteria
in urine. The method is also likely to be adapted for a multi-
plex detection of other common urinary pathogens, as previ-
ously performed for foodborne pathogens [30].
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